Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Phoenix, Arizona 85012


The objective of this study is to assess the long-term safety of linaclotide administered to patients with chronic constipation (CC) or irritable bowel syndrome with constipation (IBS-C).


Inclusion Criteria: - Patients must have - entered study LIN-MD 01[NCT00765882] or LIN-MD-31 [NCT00948818] and at minimum completed the pre-treatment period or - completed one of the following studies: MCP-103-004 [NCT00306748], MCP-103-005 [NCT00258193], MCP-103-201 [NCT00402337], MCP-103-202 [NCT00460811] - Sexually active patients of childbearing potential agree to use birth control - Females of childbearing potential must have a negative urine pregnancy test prior to dosing - Lactating females must agree not to breastfeed - Patient must meet protocol criteria for CC or IBS-C Exclusion Criteria: - Patient must not use protocol-defined prohibited medicine - Patient is planning to receive an investigational drug at any time during the study - Patient has an unresolved AE or a clinically significant finding on a physical examination, 12-lead ECG, or clinical laboratory test



Primary Contact:

Study Director
Paul Eng, PhD
Forest Laboratories

Backup Contact:


Location Contact:

Phoenix, Arizona 85012
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: January 21, 2020

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.